SRTA
Strata Critical Medical Inc

207
Mkt Cap
$442.2M
Volume
778,256.00
52W High
$6.02
52W Low
$2.35
PE Ratio
-20.50
SRTA Fundamentals
Price
$5.09
Prev Close
$5.12
Open
$5.14
50D MA
$4.77
Beta
1.74
Avg. Volume
1.01M
EPS (Annual)
-$0.3524
P/B
1.56
Rev/Employee
$772,338.51
Loading...
Loading...
News
all
press releases
AMN Healthcare Services (AMN) Beats Q3 Earnings and Revenue Estimates
AMN Healthcare (AMN) delivered earnings and revenue surprises of +105.26% and +3.15%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates
Biodesix (BDSX) delivered earnings and revenue surprises of +27.50% and +2.68%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Strength Seen in Teladoc (TDOC): Can Its 6.3% Jump Turn into More Strength?
Teladoc (TDOC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·2mo ago
News Placeholder
JOBY or EVTL: Which eVTOL Stock Possesses an Edge Currently?
Vertical Aerospace edges past Joby Aviation with stronger finances, milestones, and stock performance in the fast-growing eVTOL space.
Zacks·3mo ago
News Placeholder
The Zacks Analyst Blog Highlights Joby Aviation, Archer Aviation and Strata Critical Medical
Joby Aviation's eVTOL progress and Blade buyout fuel optimism, but overvaluation and commercialization risks make JOBY a Sell-rated stock.
Zacks·3mo ago
News Placeholder
JOBY's Premium Valuation: Should You Buy, Sell or Hold the Stock Now?
Joby shines with autonomous flight milestones and Blade's passenger business buyout, but premium valuation and looming risks weigh on its outlook.
Zacks·3mo ago
<
...
1
>

Latest SRTA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.